CLINICAL_TRIALS
trial_result
· 2019-01-24
Clinical Trial Update: A Study of LY3025876 in Participants With Diabetes [Phase 1]
Summary
A Phase 1 study of LY3025876 in participants with Type 2 Diabetes Mellitus has completed, with results posted by the sponsor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2019-01-24